Recruiting A Study of Nemtabrutinib in Participants With Moderate Hepatic Impairment (MK-1026-015) NCT06442436 Conditions Hepatic Impairment (HI) Locations Clinical Pharmacology of Miami ( Site 0003) — Miami, Florida, United States Orlando Clinical Research Center ( Site 0001) — Orlando, Florida, United States Texas Liver Institute ( Site 0002) — San Antonio, Texas, United States View Trial Details
Recruiting A Pharmacokinetic Study of D-2570 in Participants With Hepatic Impairment and Normal Hepatic Function NCT07715149 Conditions Healthy Adult Participants, Hepatic Impairment (HI) Locations The First Affiliated Hospital of Bengbu Medical University — Bengbu, Anhui, China View Trial Details
Recruiting A Study to Evaluate EDG-7500 in Adults With Hepatic Impairment NCT07324616 Conditions Hepatic Impairment (HI) Locations The University of Miami Division of Clinical Pharmacology — Miami, Florida, United States Orlando Clinical Research Center — Orlando, Florida, United States View Trial Details
Completed A Varegacestat Hepatic Impairment Study NCT06841315 Conditions Healthy Volunteer, Hepatic Impairment (HI) Locations Orlando Clinical Research Center — Orlando, Florida, United States The Texas Liver Institute — San Antonio, Texas, United States View Trial Details
